Michael Milos Thornton, Chief Technology Officer at ENDRA Life Sciences Inc. (NDRA), sold 33,750 shares at $2.37 ($82K) on 2021-03-29, disclosed to the SEC on 2021-04-07.
Scheduled sale ($82k) by Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.37 | 18,750 | $44K | 53.9% |
| 2 | $2.53 | 15,000 | $38K | 46.1% |
| Total | $2.44 avg | 33,750 | $82K | 100% |
| Filing → |
| NDRA | BUY | 2022-08-24 | $5K | — | Filing → |
| NDRA | BUY | 2022-05-31 | $5K | — | Filing → |
| NDRA | BUY | 2022-05-23 | $6K | — | Filing → |